AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	327.17B
Revenue	n/a
Net Income	n/a
Shares Out	22.49M
EPS	n/a
PE Ratio	n/a
Forward PE	39.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	276,504
Average Volume	247,291
Open	15,560
Previous Close	15,710
Day's Range	15,240 - 15,780
52-Week Range	13,480 - 25,900
Beta	1.57
RSI	30.19
Earnings Date	n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030